Form 8-K - Current report:
SEC Accession No. 0001140361-24-047246
Filing Date
2024-11-19
Accepted
2024-11-19 08:00:29
Documents
13
Period of Report
2024-11-18
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K ef20038832_8k.htm   iXBRL 8-K 25752
  Complete submission text file 0001140361-24-047246.txt   159660

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA insm-20241118.xsd EX-101.SCH 3976
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20241118_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20241118_pre.xml EX-101.PRE 16040
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20038832_8k_htm.xml XML 4065
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 241473395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)